The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be The FDA is reviewing 12 peptides for removal from its restricted listincluding BPC 157, TB 500, Semax, and GHK Cu. If it goes through, it's the biggest peptide policy shift in years. More access. Easier GHK Cu 50mg Copper Peptide Research Grade Midwest Peptide GHK Cu Copper Peptide: Dosage, Before and After Results, and How It Works Perfect B GHK Cu Cooper Peptide: The Complete Skin & Repair Guide (2026)